A novel synthetic analog of 5, 8-disubstituted quinazolines blocks mitosis and induces apoptosis of tumor cells by inhibiting microtubule polymerization.
Many mitosis inhibitors are powerful anticancer drugs. Tremendous efforts have been made to identify new anti-mitosis compounds for developing more effective and less toxic anti-cancer drugs. We have identified LJK-11, a synthetic analog of 5, 8-disubstituted quinazolines, as a novel mitotic blocker. LJK-11 inhibited growth and induced apoptosis of many different types of tumor cells. It prevented mitotic spindle formation and arrested cells at early phase of mitosis. Detailed in vitro analysis demonstrated that LJK-11 inhibited microtubule polymerization. In addition, LJK-11 had synergistic effect with another microtubule inhibitor colchicine on blocking mitosis, but not with vinblastine or nocodazole. Therefore, LJK-11 represents a novel anti-microtubule structure. Understanding the function and mechanism of LJK-11 will help us to better understand the action of anti-microtubule agents and to design better anti-cancer drugs.
Tian
Wei
W
The School of Life Science and Biopharmaceutics of Shenyang Pharmaceutical University, Liaoning, China.
Qin
Lili
L
Song
Qiaoling
Q
He
Li
L
Ai
Midan
M
Jin
Yi
Y
Zhou
Zuyu
Z
You
Song
S
Long
Yaqiu
Y
Yu
Qiang
Q
D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D003078:Colchicine / Q000494:pharmacology; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D016195:G2 Phase / Q000187:drug effects; D006801:Humans; D008870:Microtubules / Q000187:drug effects* / Q000378:metabolism*; D008938:Mitosis / Q000187:drug effects*; D010766:Phosphorylation / Q000187:drug effects; D019000:Phosphotyrosine / Q000378:metabolism; D011799:Quinazolines / Q000737:chemistry / Q000494:pharmacology*; D008941:Spindle Apparatus / Q000187:drug effects / Q000378:metabolism; D014404:Tubulin / Q000378:metabolism
C551903:LJK 11 compound; D011799:Quinazolines; D014404:Tubulin; D019000:Phosphotyrosine; D003078:Colchicine
Eur J Cancer. 1997 Mar;33(3):463-70
9155533
Oncol Rep. 2002 Mar-Apr;9(2):379-82
11836612
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9552-6
8105478
Am J Pathol. 2003 Sep;163(3):1109-16
12937152
Apoptosis. 2003 Oct;8(5):413-50
12975575
Bioessays. 1998 Oct;20(10):830-6
9819570
Clin Cancer Res. 2000 May;6(5):1978-87
10815923
Cell Biochem Funct. 2006 Sep-Oct;24(5):419-29
15912561
Cancer Res. 2001 Jul 15;61(14):5480-5
11454695
J Cell Sci. 2001 Jan;114(Pt 2):281-91
11148130
Eur J Cancer. 1997 Mar;33(3):486-92
9155536
Mol Cell Biochem. 2003 Nov;253(1-2):41-7
14619954
FASEB J. 2004 Oct;18(13):1612-4
15319373
Bioorg Med Chem. 2005 Oct 1;13(19):5613-22
15993078
Annu Rev Med. 2002;53:615-27
11818492
Anticancer Drugs. 2004 Jul;15(6):553-8
15205596
J Reprod Dev. 2004 Dec;50(6):647-52
15647616
Cancer Res. 2002 Apr 1;62(7):1935-8
11929805
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10560-4
9380674
J Natl Cancer Inst. 2000 Feb 2;92(3):217-24
10655438
Cancer Res. 2003 Jun 1;63(11):2794-801
12782584
Mol Cancer Ther. 2004 Jun;3(6):661-9
15210851
Cancer Res. 2004 Jul 1;64(13):4621-8
15231674
Mol Cancer Ther. 2002 Nov;1(13):1201-9
12479701
J Cell Sci. 1992 Jul;102 ( Pt 3):401-16
1506423
Curr Opin Cell Biol. 1998 Feb;10(1):123-30
9484604
Chromosome Res. 2004;12(6):599-616
15289666
J Ethnopharmacol. 1996 Apr;51(1-3):239-53; discussion 253-4
9213622
Mol Cancer Ther. 2003 May;2(5):427-36
12748304
J Clin Oncol. 1999 Mar;17(3):1061-70
10071301
Bioorg Med Chem Lett. 2006 Nov 15;16(22):5864-9
16942876
J Clin Invest. 2002 Jul;110(1):91-9
12093892
Int J Cancer. 2006 Feb 15;118(4):1032-40
16152590
Cell Struct Funct. 1999 Oct;24(5):329-35
15216890
Carcinogenesis. 1999 Jul;20(7):1161-8
10383885
Nat Rev Cancer. 2004 Apr;4(4):253-65
15057285
J Neurooncol. 2000 Apr;47(2):133-40
10982154